3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
17
Prostate Cancer Metastatic
3
Neoplasms
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Carcinoma, Transitional Cell
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Metastatic Breast Cancer With Intracranial Metastases
1
Malignant Solid Tumor - Malignant Nervous System Neoplasm
1
Lymphadenopathy
1
Hormone-Resistant Prostate Cancer
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
76
Cetuximab
60
pembrolizumab
56
Radiotherapy, Intensity-Modulated
37
Radiotherapy
33
Carboplatin
31
Docetaxel
30
Fluorouracil
27
Nivolumab
26
Paclitaxel
20
Platinum
10
Albumin-Bound Paclitaxel
9
Surgical Procedures, Operative
8
Radiosurgery
8
Radiation
8
Erlotinib Hydrochloride
8
durvalumab
7
Bevacizumab
7
1,2-diaminocyclohexaneplatinum II citrate
7
epacadostat
6
Biopsy
6
Radiotherapy, Conformal
5
Ipilimumab
5
Immunoglobulin G
5
Gemcitabine
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
utomilumab
4
tremelimumab
4
palbociclib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Squamous Cell Carcinoma of Head and Neck
×
cabazitaxel
×
Clear all
No trials found.